ELI LILLY AND COMPANY (LLY) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $588.00M; Additional Paid in Capital, Common StockUSD $7.12B; Treasury Stock, Common, ValueUSD (m); Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-2.76B.
- 2026-03-31: Common Stock, Value, IssuedUSD $590.00M; Additional Paid in Capital, Common StockUSD $6.92B; Treasury Stock, Common, ValueUSD (m); Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-2.83B.
- 2025-12-31: Common Stock, Value, IssuedUSD $590.00M; Additional Paid in Capital, Common StockUSD $7.35B; Treasury Stock, Common, ValueUSD (m); Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-2.88B.
- 2025-09-30: Common Stock, Value, IssuedUSD $591.40M; Additional Paid in Capital, Common StockUSD $7.23B; Treasury Stock, Common, ValueUSD $62.50M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-3.21B.
ELI LILLY AND COMPANY Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Treasury Stock, Common, Value USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | Treasury Stock, Value, Acquired, Cost Method USD | Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax USD | Treasury Stock, Value USD | Deferred Employee Stock Ownership Plan, Issuance of Shares or Sale of Treasury Shares USD | Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax USD | AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax USD | Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax USD | Treasury Stock, Retired, Cost Method, Amount USD | Treasury Stock, Shares, Acquired shares | Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax USD | Treasury Stock, Shares shares |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $588.00M | $7.12B | (m) | $-2.76B | $31.89B | $33.88B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $590.00M | $6.92B | (m) | $-2.83B | $29.51B | $31.20B | (m) | 3 month · $2.30B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $590.00M | $7.35B | (m) | $-2.88B | $24.47B | $26.54B | (m) | 12 month · $4.10B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $591.40M | $7.23B | $62.50M | $-3.21B | $22.25B | $23.79B | $23.85B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $592.00M | $7.09B | $55.40M | $-3.72B | $17.38B | $18.27B | $18.35B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $592.60M | $6.91B | $49.50M | $-3.77B | $15.10B | $15.76B | $15.85B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $592.00M | $7.44B | $49.50M | $-4.32B | $13.54B | $14.27B | $14.27B | 12 month · $2.50B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $593.90M | $7.34B | $32.70M | $-4.27B | $13.63B | $14.24B | $14.32B | (m) | 3 month · $-23.80M 9 month · $-81.40M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $594.20M | $7.21B | $32.70M | $-4.38B | $13.18B | $13.56B | $13.64B | (m) | 3 month · $-24.70M 6 month · $-57.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $594.20M | $7.01B | $32.70M | $-4.30B | $12.55B | $12.81B | $12.90B | (m) | 3 month · $-32.90M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $593.60M | $7.25B | $44.20M | $-4.33B | $10.31B | $10.77B | $10.86B | 12 month · $750.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $593.60M | $7.16B | $45.00M | $-3.78B | $10.31B | $11.22B | $11.31B | (m) | 3 month · $-15.90M 9 month · $-21.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $593.60M | $6.95B | $45.00M | $-3.79B | $10.37B | $11.06B | $11.15B | (m) | 3 month · $-15.30M 6 month · $-5.80M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $593.50M | $6.79B | $45.00M | $-3.78B | $10.64B | $11.19B | $11.29B | (m) | 3 month · $9.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $594.10M | $6.92B | $50.50M | $-3.84B | $10.04B | $10.65B | $10.78B | 12 month · $1.50B | 12 month · $-250.80M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | $594.10M | $6.83B | $50.50M | $-4.30B | $10.01B | $10.07B | $10.17B | (m) | 3 month · $-71.10M 9 month · $-192.40M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $594.10M | $6.75B | $50.50M | $-4.29B | $8.56B | $8.54B | $8.66B | (m) | 3 month · $-60.00M 6 month · $-121.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $594.10M | $6.66B | (m) | $-4.23B | $9.37B | $9.33B | $9.46B | (m) | 3 month · $-61.30M | $50.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $596.30M | $6.83B | $52.70M | $-4.34B | $8.96B | $8.98B | $9.15B | 8 month · $250.00M 12 month · $1.25B | 12 month · $-357.90M | $52.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | $598.20M | $6.76B | (m) | $-6.17B | $9.64B | $7.76B | $7.95B | (m) | 3 month · $-89.40M 9 month · $-269.20M | $52.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | $598.10M | $6.67B | (m) | $-6.29B | $8.53B | $6.44B | $6.66B | (m) | 3 month · $-90.10M 6 month · $-179.80M | $52.70M | (m) | (m) | (m) | (m) | (m) | 3 month · 0.00 6 month · 0.00 | (m) | (m) |
| 2021-04-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 4 month · $1.00B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | $599.70M | $6.58B | (m) | $-6.40B | $9.18B | $6.90B | $7.10B | (m) | 3 month · $-89.70M | $52.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $598.20M | $6.78B | (m) | $-6.50B | $7.83B | $5.64B | $5.83B | 12 month · $500.00M | 12 month · $-283.40M | $55.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | $598.10M | $6.70B | (m) | $-6.56B | $7.15B | $4.83B | $5.00B | (m) | 3 month · $-33.40M 9 month · $-202.80M | $55.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | $598.10M | $6.63B | (m) | $-6.68B | $6.62B | $4.09B | $4.27B | (m) | 3 month · $-88.90M 6 month · $-169.40M | $55.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | $598.10M | $6.56B | (m) | $-6.89B | $5.88B | $3.08B | $3.20B | (m) | 3 month · $-80.50M | $55.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $598.80M | $6.69B | (m) | $-6.52B | $4.92B | $2.61B | $2.70B | 12 month · $4.40B | 12 month · $-214.20M | $60.80M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | $600.40M | $6.61B | (m) | $-5.73B | $4.98B | $3.38B | $3.46B | (m) | 3 month · $-47.90M 9 month · $-231.20M | $60.80M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | $603.70M | $6.53B | (m) | $-5.60B | $4.32B | $2.78B | $2.86B | (m) | 3 month · $-49.90M 6 month · $-183.30M | $62.10M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | $607.10M | $5.76B | (m) | $-5.69B | $4.88B | $2.48B | $2.56B | (m) | 3 month · $-133.40M | $62.10M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $661.00M | $6.58B | (m) | $-5.73B | $11.40B | $9.83B | $10.91B | 12 month · $4.15B | 12 month · $-190.50M | $69.40M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | $667.10M | $6.52B | (m) | $-5.44B | $14.41B | $13.08B | $14.15B | (m) | 3 month · $-49.90M 9 month · $-140.80M | $69.40M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | $673.50M | $5.83B | (m) | $-6.11B | $14.25B | $11.56B | $11.62B | (m) | 3 month · $-29.20M 6 month · $-90.90M | $69.40M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | $680.80M | $5.76B | (m) | $-5.44B | $16.61B | $14.53B | $14.59B | 3 month · $1.10B | 3 month · $-61.70M | $69.30M | (m) | (m) | (m) | (m) | (m) | 3 month · 14.10M | (m) | (m) |
| 2017-12-31 | $687.90M | $5.82B | (m) | $-5.72B | $13.89B | $11.59B | $11.67B | 12 month · $359.80M | 12 month · $-60.50M | $75.80M | (m) | (m) | (m) | (m) | 12 month · $0.00 | (m) | (m) | (m) |
| 2017-09-30 | $688.50M | $5.75B | (m) | $-4.61B | $16.15B | $14.89B | $14.96B | 9 month · $259.90M | 3 month · $-26.70M 9 month · $-62.80M | $75.80M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | $688.50M | $5.69B | (m) | $-4.77B | $15.59B | $14.10B | $14.17B | 6 month · $259.90M | 3 month · $-27.30M 6 month · $-36.10M | $75.80M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | $690.00M | $5.62B | (m) | $-5.06B | $15.88B | $14.03B | $14.10B | 3 month · $60.00M | 3 month · $-8.80M | $75.80M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $688.50M | $5.64B | (m) | $-5.27B | $16.05B | $14.01B | $14.08B | 12 month · $540.10M | 12 month · $-250.70M | $80.50M | (m) | (m) | (m) | (m) | 12 month · $0.00 | (m) | (m) | (m) |
| 2016-09-30 | $690.40M | $5.65B | (m) | $-4.26B | $16.60B | $15.59B | $15.62B | 9 month · $300.10M | 3 month · $-40.10M 9 month · $-205.60M | $80.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | $690.30M | $5.59B | (m) | $-4.37B | $15.82B | $14.64B | $14.66B | 6 month · $300.10M | 3 month · $-49.90M 6 month · $-165.50M | $80.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | $690.30M | $5.52B | (m) | $-4.26B | $16.16B | $15.01B | $15.03B | 3 month · $300.10M | 3 month · $-115.60M | $80.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | $691.30M | $5.55B | (m) | $-4.58B | $16.01B | $14.57B | $14.59B | 12 month · $749.50M | 12 month · $-116.20M | $90.00M | (m) | (m) | (m) | (m) | 12 month · $0.00 | (m) | (m) | 796.00K |
| 2015-09-30 | $693.00M | $5.44B | (m) | $-4.67B | $16.86B | $15.22B | $15.24B | 9 month · $496.60M | 3 month · $37.10M 9 month · $-37.90M | $90.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | $693.30M | $5.37B | (m) | $-4.40B | $16.11B | $14.67B | $14.71B | 6 month · $435.50M | 3 month · $-30.80M 6 month · $-75.00M | $90.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | $694.10M | $5.28B | (m) | $-4.66B | $16.71B | $14.92B | $14.95B | 3 month · $310.60M | 3 month · $-44.20M | $90.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | $694.60M | $5.29B | (m) | $-3.99B | $16.48B | $15.37B | $15.39B | 12 month · $800.00M | 12 month · $19.20M | $91.40M | (m) | (m) | (m) | (m) | 12 month · $0.00 | (m) | (m) | 810.00K |
| 2014-09-30 | $696.60M | $5.22B | (m) | $-2.55B | $17.41B | $17.67B | $17.68B | 9 month · $500.00M | 3 month · $200.00K 9 month · $-41.40M | $91.40M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | $699.00M | $5.12B | (m) | $-1.94B | $17.20B | $17.98B | $17.99B | 6 month · $200.00M | 3 month · $-19.80M 6 month · $-41.60M | $91.40M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | $700.10M | $5.03B | (m) | $-1.96B | $17.67B | $18.34B | $18.35B | 3 month · $55.00M | 3 month · $-21.80M | $91.40M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | $698.50M | $5.05B | (m) | $-2.00B | $16.99B | $17.63B | $17.64B | 12 month · $1.60B | 12 month · $-318.70M | $93.60M | (m) | (m) | (m) | (m) | 12 month · $0.00 | (m) | (m) | 833.00K |
| 2013-09-30 | $704.70M | $5.04B | (m) | $-3.56B | $17.81B | (m) | $16.90B | (m) | 3 month · $-82.30M 9 month · $-233.70M | $93.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | $704.70M | $4.97B | (m) | $-3.95B | $16.61B | (m) | $15.24B | 6 month · $1.10B | 3 month · $-77.10M 6 month · $-151.40M | $93.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | $704.50M | $4.90B | (m) | $-4.01B | $16.46B | (m) | $14.96B | 3 month · $1.10B | 3 month · $-74.30M | $93.60M | (m) | $80.80M | $90.50M | $4.09B | (m) | (m) | $-99.00M | (m) |
| 2012-12-31 | $716.60M | $4.96B | (m) | $-3.80B | $16.09B | $14.77B | $14.77B | 12 month · $819.20M | (m) | $192.40M | (m) | $426.80M | $72.50M | $4.20B | 12 month · $100.00K | (m) | $-101.20M | 2.85M |
| 2012-09-30 | $725.80M | $4.92B | (m) | $-3.54B | $17.06B | (m) | $16.06B | 9 month · $0.00 | (m) | $94.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | $725.80M | $4.89B | (m) | $-3.93B | $15.74B | (m) | $14.31B | (m) | (m) | $94.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | $725.80M | $4.86B | (m) | $-3.55B | $15.91B | (m) | $14.82B | (m) | (m) | $94.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | $724.10M | $4.89B | (m) | $-3.86B | $14.90B | $13.54B | $13.54B | (m) | (m) | $95.30M | $0.00 | (m) | (m) | (m) | 12 month · $0.00 | (m) | (m) | 853.00K |
| 2011-09-30 | $724.10M | $4.84B | (m) | $-2.51B | $15.13B | (m) | $15.06B | (m) | (m) | $95.30M | $-14.40M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | $724.10M | $4.79B | (m) | $-2.01B | $13.89B | (m) | $14.28B | (m) | (m) | $95.30M | $-10.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | $724.10M | $4.74B | (m) | $-2.19B | $13.79B | (m) | $13.93B | (m) | (m) | $95.30M | $-10.90M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $721.30M | $4.80B | (m) | $-2.67B | $12.73B | $12.42B | $12.41B | (m) | (m) | $96.40M | $-52.40M | (m) | (m) | (m) | (m) | (m) | (m) | 864.00K |
| 2010-09-30 | $721.30M | $4.74B | (m) | $-2.53B | $12.65B | (m) | $12.41B | (m) | (m) | $97.40M | $-58.10M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | $721.30M | $4.67B | (m) | $-3.31B | $11.34B | (m) | $10.24B | (m) | (m) | $97.40M | $-73.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | $721.30M | $4.62B | (m) | $-2.78B | $11.08B | (m) | $10.46B | (m) | (m) | $97.40M | $-75.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $718.70M | $4.64B | (m) | $-2.47B | $9.83B | (m) | $9.53B | (m) | (m) | $98.50M | $-77.40M | (m) | (m) | (m) | (m) | (m) | (m) | 882.00K |
| 2009-09-30 | $718.70M | $4.56B | (m) | $-2.18B | $9.99B | (m) | $9.90B | (m) | (m) | $98.50M | $-79.90M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | $718.70M | $4.46B | (m) | $-2.47B | $9.05B | (m) | $8.56B | (m) | (m) | $98.50M | $-82.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | $711.10M | $3.98B | (m) | $-2.79B | $7.65B | (m) | $6.74B | (m) | (m) | $99.20M | $-86.30M | (m) | (m) | (m) | (m) | (m) | (m) | 889.00K |
| 2006-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $2.58B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Akari Therapeutics Plc (AKTX) | $1,527.991B | -47,921.42 | |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |